Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
136.00    -5.25 (-3.72%)
Bid:
136.00
Ask:
144.50
Spread: 8.50 (6.25%)
Market Cap: £106.72m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Changes

30 Oct 2023 07:00

RNS Number : 6126R
Xaar PLC
30 October 2023
Β 

30 October 2023

Β 

Xaar plc

Β 

Board changes

Β 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, announces the appointment of Jacqueline Sutton MBE as Non-Executive Director.

Β 

Jacqueline joins the Board with effect from 1 November 2023 and on appointment, will serve as a member of the Audit, Remuneration and Nomination Committees. In accordance with the Board's succession plan disclosed in the 2022 Annual Report, Chris Morgan will step down as a Non-Executive Director of the Company on 30 November 2023.

Β 

Jacqueline is a very accomplished senior executive having held, from 2008 to 2021, several senior leadership roles in Rolls-Royce plc's largest division (Civil Aerospace). Most recently, Jacqueline was Chief Customer Officer of Civil Aerospace, Rolls-Royce Group, where she was responsible for the global customer base, including airline operators, leasing companies and aircraft manufacturers across the world. Leading a multinational global team, she was accountable for the order book, revenue, and cash, as well as marketing and customer support. Prior to joining Rolls-Royce, Jacqueline held senior management roles with GE Aviation Systems (formerly Smiths Aerospace),

Β 

Jacqueline is currently a non-executive director of Farnborough International, the Women in Aviation & Aerospace Charter and a Trustee on the Council of St John's College, Durham University.

Β 

In 2022, Jacqueline was awarded an MBE in the late Queen's Platinum Jubilee Birthday Honours List for services to the economy.

Β 

Andrew Herbert, Chairman, commented:

Β 

"We are delighted to welcome an executive of Jacqueline's calibre to the Board. Her experience of managing global customers and revenue generation in a fast-moving and complex sector are competencies that will greatly benefit Xaar. I would like to thank Chris for his huge contribution to the Board of Xaar as a director since 2016 and wish him the very best for the future."

Β 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Jacqueline Sutton.

Β 

Β 

Β 

Enquiries:

Β 

Xaar plc

+44 (0) 1223 423 663Β 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Β 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUBRBROUURUAA
Date   Source Headline
2nd Jan 20182:52 pmRNSTotal Voting Rights
14th Dec 201711:11 amRNSAgreement
1st Dec 20171:55 pmRNSTotal Voting Rights
21st Nov 20178:56 amRNSNOTIFICATION OF MAJOR HOLDINGS
20th Nov 20177:00 amRNSTrading Statement
15th Nov 20179:20 amRNSXaar strengthens 2020 vision with two developments
1st Nov 201710:04 amRNSTotal Voting Rights
2nd Oct 20172:37 pmRNSTotal Voting Rights
8th Sep 201711:34 amRNSDirector/PDMR Shareholding
6th Sep 20172:43 pmRNS2017 Interim Results
6th Sep 20177:00 amRNS2017 Interim Results
1st Sep 201712:21 pmRNSTotal Voting Rights
17th Aug 201711:55 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Aug 20177:00 amRNSDirector change
1st Aug 20172:26 pmRNSTotal Voting Rights
12th Jul 20177:00 amRNSTrading Statement
4th Jul 20177:00 amRNSNotice of Scheduled Trading Statement
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20179:36 amRNSBlock listing Interim Review
1st Jun 201711:33 amRNSTotal Voting Rights
18th May 201711:10 amRNSREPLACEMENT: Grant of Options
18th May 20178:56 amRNSGrant of Options
16th May 20171:24 pmRNSResult of AGM
2nd May 20171:13 pmRNSTotal Voting Rights
2nd May 20177:00 amRNSBoard Appointment
26th Apr 201710:05 amRNSNotice of 2017 AGM
18th Apr 20177:00 amRNSDirector/PDMR Shareholding - SIP Purchase
11th Apr 20179:35 amRNSDirector/PDMR Shareholding
11th Apr 20179:19 amRNSDirector/PDMR Shareholding
6th Apr 20174:19 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
5th Apr 201712:34 pmRNSTotal Voting Rights - Replacement
3rd Apr 20172:08 pmRNSTotal Voting Rights
3rd Apr 20179:43 amRNSWORLD LEADING 3D CENTRE FORMALLY OPENED
29th Mar 20171:11 pmRNSConfirmation of Board Changes
28th Mar 20173:22 pmRNSDirector/PDMR Shareholding
24th Mar 20172:42 pmRNSNotification of Major Interest in Shares
22nd Mar 20177:00 amRNSFinal Results
8th Mar 20173:11 pmRNSNotice of Scheduled Results
1st Mar 20174:38 pmRNSTotal Voting Rights
1st Feb 20175:42 pmRNSTotal Voting Rights
24th Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSXerox partnership agreement
3rd Jan 20174:23 pmRNSBlock listing Six Monthly Return
3rd Jan 20174:20 pmRNSTotal Voting Rights
15th Dec 20167:00 amRNSScheduled Trading Statement
15th Dec 20167:00 amRNSInvestment in 3D Printing
12th Dec 20167:00 amRNSNotice of Scheduled Trading Statement
1st Dec 20161:52 pmRNSTotal Voting Rights
1st Nov 20163:48 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSBoard change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.